GIS trade ideas
Gilead GILD w24 2021. Short to 63Weekly
Consolidation
Daily
Below SR level
Also I expect sellers pressure from those who buy it in 2020 but didnt get profit.
Short
Open 66
TP 63
SL
68
RR 2,17
GILD: Breakout Confirmed, 11.19% Potential Profit!Description: GILD is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $66.7 - $68.7
2. Take profit: $75.29
3. Stop Loss: $65.68
4. Risk To Reward: 1 / 4
5. Accuracy Rating: 83%
IRON TARIHi guys,
IV keeps quite low, this week too, so I have to reverse my Tari condor.
3 weeks 6% strike, 37% of probability to end ITM. So I reverse the condor, so the odds come to my side, because I have 63% of probability to gain a profit, and my RR is almost 1:1 ( 0.85 commisions incl.)
So subscribe for free to trade with Tari Condor!
Enjoy your wallet!
Tari
$GILD - two screeners say to enterWatching this one. I have two screeners suggesting it plus its between two volume shelves.
GILD: Breakout Confirmed, 13.54% Potential Profit!Description: GILD is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $67.1 - $69.1
2. Take profit: $76.62
3. Stop Loss: $65.46
4. Risk To Reward: 1 / 5
5. Accuracy Rating: 83%
$GILD Gilead Sciences No Trade Zone
Gilead is once again stuck within a congestion channel and makes it not worthy of a trade into earnings.
Alerts are set for a break from this channel for a short or long opportunity in the future.
$GILD Gilead Breaks above the 200MA
The stock has finally shown some signs of a longer term reversal.
-Volume impressive
-Golden cross imminent
-Indicators bullish.
Potential long above $66.66
GILD Long Wedge Breakout
one swing crossed SMA50 and SMA200
Entry 66.3
Stop 63
Target 72
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
$GILD with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $GILD after a Negative Under reaction following its earnings release placing the stock in drift A
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
GILD Scienced - GILD: Hepatitis Cures for C, B and DFUNDAMENTALS:
GILD (Gilead Sciences) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D.
TECHNICALS:
Monthly:
wedge pattern and volume divergence tells of that institutions and investors may begin to sponsor this company again.
MACD divergence
Weekly:
regular divergence confirms the case for the monthly pattern
breach to new minor highs within a larger pattern
positive MACD development
volume support
Daily:
Crown pattern
Volume confirmation
Daily horizontal support
Daily wedge pattern being tested and broken
$GILD - Positive trend after breaking above the local channelMain resistance for the next targets mentioned above is 65.7$.
Not recommended to buy or sell GILD stock.
GILEAD upward channelNASDAQ:GILD
- #GILD exit the bearish channel at the end of December 2021
- Series of higher highs and higher lows since January 2021
- Lower end of the channel coincides with the 50MA
- MACD sloping up
- RSI at good level
Buy price at USD 64.55
1st TP at USD 68.00
2nd TP at USD 72.00
SL at 61.00
Biopharma Play Here we see the monthly price trend for GILD if you zoom out further there could be a potential giant bill flag but if we can’t get over that POC I won’t be holding
GILD FORECAST ☀️I know an irregular flat when I see one. It may not rise as much as the shadowed arrow, because the div yield is hefty. I try to open positions in options whose stocks have div yield < 2%, market cap >$15 B and beta > 1. Thats my criteria trichotomy.
